Flagship Biosciences L.L.C.

Flagship Biosciences is setting the standard for quality in quantitative histopathology services to the pharmaceutical and medical device industries.

Founded in 2009 by a unique team of pathologists and image analysis and biological scientists, Flagship now works with over 100 biotech, pharma and device clients in all disciplines of tissue analysis. In 2012, Flagship acquired IHCtech, a leading research histology and IHC laboratory that has experience working with and successfully applying over 400 antibodies since 2002.

The Flagship team provides substantial experience in tissue analysis through a team of dedicated pathologists, biologists, image analysis engineers, histologists and regulatory personnel. Projects range from early stage, exploratory, and tissue microarray studies through large, late stage, CLIA-based clinical trials or IDE image analysis companion diagnostics filings. Flagship is platform agnostic on both image analysis and in immunohistochemistry or immunofluorescence, bringing the best solution to the particular client’s tissue challenge.